Literature DB >> 15241537

[Sports as therapy].

Rainer Hambrecht1.   

Abstract

Over the last 2 decades the clinical application of physical exercise as a therapeutic strategy has developed from rehabilitation to prevention and treatment of cardiovascular diseases. This shift in clinical application was accompanied by a more systematic research approach of the involved mechanisms and the objective clinical assessment of sport interventions using prospective randomized clinical trials. This ongoing process established physical exercise as an evidence-based and guideline-oriented treatment option. In stable coronary artery disease (CAD), exercise therapy has long been used for rehabilitation purposes following an acute myocardial infarction. A recent meta-analysis revealed a significant 27% reduction of total mortality among training patients. Four mechanisms are considered important mediators of the reduced cardiac event rate: improvement of endothelial function, reduced progression of coronary lesions, reduced thrombogenic risk, and improved collateralization. The therapeutic benefit of regular physical exercise has also been confirmed in direct comparison with an interventional strategy: a 12-month exercise therapy in stable CAD patients was associated with a higher event-free survival as compared to conventional percutaneous coronary intervention. In stable chronic heart failure (CHF), physical activity was traditionally discouraged-with negative consequences for the patients: exercise intolerance worsened, the progression of disease-related muscular atrophy accelerated. A carefully designed exercise program at 50-70% of the maximal oxygen uptake was effective in improving exercise capacity by 12-32%. In a recent meta-analysis, exercise therapy reduced the relative risk of CHF mortality by 35% and CHF-related hospitalizations by 28%. Considering the growing body of evidence in favor of sport as a therapy, training interventions should be considered additional/alternative therapeutic strategies as compared with established pharmacological/interventional options.

Entities:  

Mesh:

Year:  2004        PMID: 15241537     DOI: 10.1007/s00059-004-2583-3

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  4 in total

1.  [Electromyostimulation (EMS) in cardiac patients. Will EMS training be helpful in secondary prevention?].

Authors:  Dirk Fritzsche; Andreas Fruend; Sören Schenk; Klaus-Peter Mellwig; Heinz Kleinöder; Jan Gummert; Dieter Horstkotte
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

2.  Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

Authors:  W Doehner; S D Anker
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

3.  Cardiovascular prevention in clinical practice (ESC and German guidelines 2007).

Authors:  Helmut Gohlke; Christian Albus; Detlef Bernd Gysan; Harry W Hahmann; Peter Mathes
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

4.  [Sport for pacemaker patients].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.